Cargando…

Ataxin-2 gene: a powerful modulator of neurological disorders

PURPOSE OF REVIEW: To provide an update on the role of Ataxin-2 gene (ATXN2) in health and neurological diseases. RECENT FINDINGS: There is a growing complexity emerging on the role of ATXN2 and its variants in association with SCA2 and several other neurological diseases. Polymorphisms and intermed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Laffita-Mesa, Jose Miguel, Paucar, Martin, Svenningsson, Per
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	MOVEMENT DISORDERS: Edited by Per Svenningsson
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279897/ https://www.ncbi.nlm.nih.gov/pubmed/34010218 http://dx.doi.org/10.1097/WCO.0000000000000959

Ejemplares similares

The state of telemedicine for persons with Parkinson's disease
por: van den Bergh, Robin, et al.
Publicado: (2021)

APOE ε4 influences cognitive decline positively in APP and negatively in PSEN1 mutation carriers with autosomal‐dominant Alzheimer's disease
por: Almkvist, Ove, et al.
Publicado: (2022)

Management of rare movement disorders in Europe: outcome of surveys of the European Reference Network for Rare Neurological Diseases
por: Painous, C., et al.
Publicado: (2020)

Are ATXN2 variants modifying our understanding about neural pathogenesis, phenotypes, and diagnostic?
por: Laffita-Mesa, Jose Miguel, et al.
Publicado: (2022)

Effects of TPH2 gene variation and childhood trauma on the clinical and circuit-level phenotype of functional movement disorders
por: Spagnolo, Primavera A, et al.
Publicado: (2020)

Movement Disorders in Childhood Thalamic Tumors
por: Garcia-Sosa, Rebecca, et al.
Publicado: (2018)

De Novo Mutations in Ataxin-2 Gene and ALS Risk
por: Laffita-Mesa, José Miguel, et al.
Publicado: (2013)

The Addenbrooke's Cognitive Examination for the differential diagnosis and longitudinal assessment of patients with parkinsonian disorders
por: Rittman, Timothy, et al.
Publicado: (2013)

Triheptanoin dramatically reduces paroxysmal motor disorder in patients with GLUT1 deficiency
por: Mochel, Fanny, et al.
Publicado: (2016)

Acute onset movement disorders in diabetes mellitus: A clinical series of 59 patients
por: Dubey, Souvik, et al.
Publicado: (2022)

A Novel Duplication in ATXN2 as Modifier for Spinocerebellar Ataxia 3 (SCA3) and C9ORF72‐ALS
por: Laffita‐Mesa, Jose Miguel, et al.
Publicado: (2020)

Prognostic predictors relevant to end-of-life palliative care in Parkinson’s disease and related disorders: a systematic review
por: Akbar, Umer, et al.
Publicado: (2021)

REM sleep behaviour disorder is associated with worse quality of life and other non-motor features in early Parkinson's disease
por: Rolinski, Michal, et al.
Publicado: (2014)

Botulinum neurotoxin treatment in jerky and tremulous functional movement disorders: a double-blind, randomised placebo-controlled trial with an open-label extension
por: Dreissen, Yasmine Emma Maria, et al.
Publicado: (2019)

Parkinson’s disease determinants, prediction and gene–environment interactions in the UK Biobank
por: Jacobs, Benjamin Meir, et al.
Publicado: (2020)

Cortical thinning is associated with disease stages and dementia in Parkinson's disease
por: Zarei, Mojtaba, et al.
Publicado: (2013)

Predictors of short-term impulsive and compulsive behaviour after subthalamic stimulation in Parkinson disease
por: Sauerbier, Anna, et al.
Publicado: (2021)

The Val158Met COMT polymorphism is a modifier of the age at onset in Parkinson's disease with a sexual dimorphism
por: Klebe, Stephan, et al.
Publicado: (2013)

Visual hallucinations in the differential diagnosis of parkinsonism
por: Bertram, Kelly, et al.
Publicado: (2012)

Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia
por: Becker, Esther B E, et al.
Publicado: (2012)

Memantine for axial signs in Parkinson's disease: a randomised, double-blind, placebo-controlled pilot study
por: Moreau, Caroline, et al.
Publicado: (2013)

The differential diagnosis of Huntington's disease-like syndromes: ‘red flags’ for the clinician
por: Martino, Davide, et al.
Publicado: (2013)

The long-term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntington's disease
por: Barker, Roger A, et al.
Publicado: (2013)

Bone health in Parkinson's disease: a systematic review and meta-analysis
por: Torsney, Kelli M, et al.
Publicado: (2014)

Fetal striatal grafting slows motor and cognitive decline of Huntington's disease
por: Paganini, Marco, et al.
Publicado: (2014)

Rest and other types of tremor in adult-onset primary dystonia
por: Erro, Roberto, et al.
Publicado: (2014)

Long-term efficacy and safety of incobotulinumtoxinA injections in patients with cervical dystonia
por: Dressler, Dirk, et al.
Publicado: (2013)

Pisa syndrome in Parkinson's disease: a mobile or fixed deformity?
por: Doherty, Karen M, et al.
Publicado: (2013)

Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with ((123)I) ioflupane in diagnosis of parkinsonian syndromes
por: Bajaj, Nin, et al.
Publicado: (2013)

PREDICT-PD: Identifying risk of Parkinson's disease in the community: methods and baseline results
por: Noyce, Alastair J, et al.
Publicado: (2014)

Effect of subthalamic nucleus deep brain stimulation on dual-task cognitive and motor performance in isolated dystonia
por: Mills, Kelly A, et al.
Publicado: (2015)

Long-term outcome of subthalamic nucleus deep brain stimulation for Parkinson's disease using an MRI-guided and MRI-verified approach
por: Aviles-Olmos, Iciar, et al.
Publicado: (2014)

Using ‘dead or dependent’ as an outcome measure in clinical trials in Parkinson's disease
por: McGhee, David, et al.
Publicado: (2015)

Selective peripheral denervation for cervical dystonia: long-term follow-up
por: Bergenheim, A Tommy, et al.
Publicado: (2015)

Language Impairment in Adolescents with Sydenham Chorea
por: Millichap, J. Gordon
Publicado: (2015)

ADCY5 Mutations and Benign Hereditary Chorea
por: Millichap, J. Gordon
Publicado: (2015)

Risk of Tics with Psychostimulants for ADHD
por: Millichap, J. Gordon
Publicado: (2015)

Structural Connectivity in Gilles de la Tourette Syndrome
por: Chelse, Ana B., et al.
Publicado: (2015)

Clinical, genetic, neurophysiological and functional study of new mutations in episodic ataxia type 1
por: Tomlinson, Susan Elizabeth, et al.
Publicado: (2013)

Statins are underused in recent-onset Parkinson's disease with increased vascular risk: findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts
por: Swallow, Diane M A, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9k6h1bddsuc9dp67c6vdvbu4pi